Joohyuk Sohn
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.2%
- Cancer Research top 0.2%
- Molecular Biology top 5%
- Genetics top 0.5%
- Co-authors
- Masakazu ToiSusana BarrigaMartin FrenzelSeung Il KimXavier PivotNawel BourayouNadia HarbeckNorikazu Masuda
- Topics
- Advanced Breast Cancer Therapies (126 papers)Cancer Treatment and Pharmacology (92 papers)HER2/EGFR in Cancer Research (91 papers)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
Joohyuk Sohn
292 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 7.9k
- Pulmonary and Respiratory Medicine 5.6k
- Cancer Research 3.3k
- Molecular Biology 1.8k
- Genetics 1.3k
Countries citing papers authored by Joohyuk Sohn
This map shows the geographic impact of Joohyuk Sohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joohyuk Sohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joohyuk Sohn more than expected).
Fields of papers citing papers by Joohyuk Sohn
This network shows the impact of papers produced by Joohyuk Sohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joohyuk Sohn. The network helps show where Joohyuk Sohn may publish in the future.
Co-authorship network of co-authors of Joohyuk Sohn
This figure shows the co-authorship network connecting the top 25 collaborators of Joohyuk Sohn. A scholar is included among the top collaborators of Joohyuk Sohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joohyuk Sohn. Joohyuk Sohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).breakdown → | 52 |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 36 | |
| 11 | 14 | |
| 12 | 2 | |
| 13 | 10 | |
| 14 | 34 | |
| 15 | 68 | |
| 16 | 9 | |
| 17 | 90 | |
| 18 | 54 | |
| 19 | 2 | |
| 20 | 4 |
About Joohyuk Sohn
Joohyuk Sohn is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 303 papers that have together received 10.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (126 papers), Cancer Treatment and Pharmacology (92 papers) and HER2/EGFR in Cancer Research (91 papers). The work is most often cited by research in Oncology (7.9k citations), Cancer Research (3.3k citations) and Pulmonary and Respiratory Medicine (5.6k citations). Joohyuk Sohn has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Masakazu Toi, Susana Barriga, Martin Frenzel, Seung Il Kim, Xavier Pivot, Nawel Bourayou, Nadia Harbeck, Norikazu Masuda, Patrick Neven and George W. Sledge. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.